The class of chemical compounds known as GRHL2 activators encompasses a diverse group of molecules that have demonstrated the ability to enhance the expression of the Grainyhead-like 2 (GRHL2) gene. GRHL2 is a transcription factor that plays a pivotal role in various cellular processes, particularly in the regulation of epithelial differentiation, cell adhesion, and tissue morphogenesis. These activators exert their influence at the molecular level by modulating the transcriptional machinery responsible for GRHL2 gene expression. They are characterized by their distinct mechanisms of action, which involve interactions with specific cellular components, including receptors, enzymes, and DNA elements. One prominent subgroup within the GRHL2 activators comprises compounds like retinoic acid and tretinoin (ATRA), which belong to the retinoid class. These compounds are known for their affinity to retinoic acid receptors (RARs), where they act as ligands to initiate transcriptional events. By binding to RARs, these activators promote the activation of the GRHL2 gene, consequently influencing the differentiation and development of epithelial tissues.
Another subset of GRHL2 activators includes histone deacetylase (HDAC) inhibitors, such as valproic acid, trichostatin A, resveratrol, sodium butyrate, and vorinostat. These compounds function by interfering with the epigenetic regulation of the GRHL2 gene. They inhibit HDAC enzymes, leading to increased histone acetylation and, in turn, a more permissive chromatin structure at the GRHL2 promoter region. This epigenetic modulation facilitates the transcriptional machinery's access to the gene, resulting in elevated GRHL2 expression. In summary, GRHL2 activators represent a chemically diverse group of compounds that share the common characteristic of stimulating the expression of the GRHL2 gene. Their mechanisms of action involve interactions with specific cellular components, such as receptors or epigenetic modifiers, ultimately leading to enhanced GRHL2 transcription. Understanding these activators and their distinct mechanisms is essential for unraveling the intricate regulatory networks that govern epithelial differentiation and tissue development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Functions as a histone deacetylase (HDAC) inhibitor, leading to increased GRHL2 expression through histone acetylation. Modulates chromatin structure. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates GRHL2 through its role as an HDAC inhibitor, promoting histone acetylation. May also involve activation of signaling pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Induces GRHL2 expression through various signaling pathways, including MAPK and NF-κB. May affect transcription factors binding to GRHL2 promoter. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Activates GRHL2 expression as a glucocorticoid receptor agonist. Modulates the binding of transcription factors to GRHL2 promoter elements. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Functions as an HDAC inhibitor, increasing GRHL2 expression through histone acetylation. Epigenetic regulation of GRHL2 promoter region. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Activates GRHL2 through various cellular pathways, including modulation of growth factor signaling and transcription factor activation. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Function as PPAR-γ agonists, influencing GRHL2 expression through PPAR-γ-mediated transcriptional regulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, leading to increased cAMP levels and subsequent activation of GRHL2 expression. May also involve cAMP-responsive elements. | ||||||